Cleared Traditional

K081262 - DC NEURO

K081262 is an FDA 510(k) clearance for DC NEURO, manufactured by Invivo Corporation. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 43-day FDA review.

K081262 · Invivo Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2008
Decision
43d
Days
Class 2
Risk

K081262 is an FDA 510(k) clearance for the DC NEURO. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Invivo Corporation (Pewaukee, US). The FDA issued a Cleared decision on June 17, 2008 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Invivo Corporation devices

FDA 510(k) Submission Details - K081262

510(k) Number K081262 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 05, 2008
Decision Date June 17, 2008
Days to Decision 43 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 107d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1151
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K081262.
STEALTHVIZ ADVANCED PLANNING APPLICATION WITH STEALTHDTI PACKAGE
K081512 · Medtronic Navigation, Inc. · Jul 2008
ULTRASOUND DATA ANALYSIS SYSTEM, MODEL DAS-RS1
K081843 · Aloka Co., Ltd. · Jul 2008
SYNGO IMAGING (VERSION V31)
K081734 · Siemens AG Medical Solutions · Jul 2008
21.3 (54CM) 2M COLOR LCD MONITOR CCL254I2 (CDL2125A)
K081055 · Totoku Electric Co., Ltd. · Jun 2008
21.3 (54CM) 3M COLOR LCD MONITOR CCL354I2 (CDL2126A)
K081056 · Totoku Electric Co., Ltd. · Jun 2008
FUJIFILM FCR VIEW, MODEL CR-VW674
K081308 · Fujifilm Medical Systems U.S.A, Inc. · Jun 2008